Blackstone Life Sciences VI - B L.P. — Form D/A

Blackstone Life Sciences VI - B L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-04-02. The offering totals $6.3B, of which $6.3B was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Joseph BarattaRelated PersonNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.Related PersonNew York, NY
n/a BXLS VI L.L.C.Related PersonNew York, NY
Mathias FavettoRelated PersonNew York, NY
John G. FinleyRelated PersonNew York, NY
Nicholas GalakatosRelated PersonNew York, NY
Elsa GelinRelated PersonNew York, NY
Ilan HalalRelated PersonNew York, NY
Eric LiawRelated PersonNew York, NY
Robert LiptakRelated PersonNew York, NY
Nentcho NentchevRelated PersonNew York, NY
Alicia NovakRelated PersonNew York, NY
Chris PlaccaRelated PersonNew York, NY
Victoria PortnoyRelated PersonNew York, NY
Omar RehmanRelated PersonNew York, NY
Christopher StrianoRelated PersonNew York, NY
Joseph BarattaExecutive OfficerNew York, NY
Alicia NovakExecutive OfficerNew York, NY
Chris G PlaccaExecutive OfficerNew York, NY
Nentcho G NentchevExecutive OfficerNew York, NY
n/a BXLS VI L.L.C.PromoterNew York, NY
Mathias G FavettoExecutive OfficerNew York, NY
Elsa G GelinExecutive OfficerNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.PromoterNew York, NY
Victoria G PortnoyExecutive OfficerNew York, NY

Other filings by this issuer (1)

FiledFormOfferingSold
2025-11-20D$3.6B

More